Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy
Authors:
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 17 (3) , e488-e493
Abstract
No abstract availableKeywords
Funding Information
- Brigham Research Institute
- Vattikuti Urology Institute
This publication has 17 references indexed in Scilit:
- Comparative methods for handling missing data in large databasesJournal of Vascular Surgery, 2013
- Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysisCancer Epidemiology, 2013
- Body Image and Bladder Cancer Specific Quality of Life in Patients With Ileal Conduit and Neobladder Urinary DiversionsUrology, 2010
- Use of Radical Cystectomy for Patients With Invasive Bladder CancerJNCI: Journal of the National Cancer Institute, 2010
- Orthotopic Neobladder versus Ileal Conduit Urinary Diversion after Cystectomy – A Quality-of-Life Based ComparisonThe Annals of The Royal College of Surgeons of England, 2009
- Health related quality of life after radical cystectomy: Comparison of ileal conduit to continent orthotopic neobladderEuropean Journal of Surgical Oncology, 2009
- Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting MethodologyEuropean Urology, 2009
- Four Years Experience in Bladder Preserving Management for Muscle Invasive Bladder CancerEuropean Urology, 2005
- Benefit of radical cystectomy in the elderly patient with significant co-morbiditiesUrologic Oncology: Seminars and Original Investigations, 2004
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003